Indication (%) | Number of hip |
Primitive coxarthrose (4.26%) | 2 |
Secondary coxarthrose |
|
-Coxarthrose post-traumatic (14.89%) | 7 |
-Coxarthrose on congenital dysplasia (10.64%) | 5 |
§ The sequelae of LCH (8.51%) | 4 |
§ Cotyloïdienne dysplasia (2.13%) | 1 |
-sequelae of primitive osteochondrite of the Hip (OPH) (2.13%) | 1 |
-sequelae of epiphysiolyse (2.13%) | 1 |
-The sequelae of coxite tuberculous infectious (6.38%) | 3 |
-Aseptic osteonecrosis of the femoral head (ONATF) (31.91%) | 15 |
§ Post-traumatic stress disorder (12.77%) | 6 |
§ Secondary to a corticosteroid (2.13%) | 1 |
§ Secondary to an ethylisme (2.13%) | 1 |
§ The idiopathic (14.89%) | 7 |
-Patella tendon inflammation of the femoral neck (2.13%) | 1 |
-Other: | 1 |
§ Neurogenic Paraosteoarthropathie (NENA) (2.13%) |
|
-Coxites inflammatory (23.40 %) | 11 |
§ Rheumatoid arthritis (PR) (10.64%) | 5 |
§ Ankylosing spondylitis (SPA) (12.76%) | 6 |